AT-752
AT-02A-002
Phase 2 small_molecule terminated
Quick answer
AT-752 for Dengue Fever is a Phase 2 program (small_molecule) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atea Pharmaceuticals
- Indication
- Dengue Fever
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated